Northwire Canada EditionWednesday, July 15, 2026
Sign inSubscribe
Northwire
⌕
EFR 18.05 −3.0% IVN 10.64 −1.3% MASS 0.090 +0.0% NTH 0.165 +0.0% LIF 26.70 −1.8% CPAU 0.155 +0.0% PTX 0.110 +0.0% VENT 0.160 +0.0% ANK 0.280 −3.5% ODV 3.31 −1.8% MINK 0.105 +0.0% ZEN 0.660 +3.1% LCE 0.250 +4.2% CBA 0.085 +0.0% SGU 0.040 +0.0% COSA 0.600 −3.2% EFR 18.05 −3.0% IVN 10.64 −1.3% MASS 0.090 +0.0% NTH 0.165 +0.0% LIF 26.70 −1.8% CPAU 0.155 +0.0% PTX 0.110 +0.0% VENT 0.160 +0.0% ANK 0.280 −3.5% ODV 3.31 −1.8% MINK 0.105 +0.0% ZEN 0.660 +3.1% LCE 0.250 +4.2% CBA 0.085 +0.0% SGU 0.040 +0.0% COSA 0.600 −3.2%
Regulatory

Zefiro Founder and Former Chairman Reports Initial Success in New York Litigation

By The Northwire Desk — AI Analysis Mar 02, 2026 · 07:08 ZEFI · 0.405 ZEFIRO METHANE CORP.
ZEFI · Price

Executive Summary

  • A New York court denied the preliminary injunction sought by a related party on February 27, 2026.
  • The Concerned Shareholders have filed a motion to dismiss the NY Litigation, scheduled for March 19, 2026.
  • The board’s issuance of 13,214,494 “Debt Settlement Shares” to interim CEO Catherine Flax and David McGrath (and his brother‑in‑law) on January 27, 2026 is being challenged; a hearing before the BC Securities Commission is set for March 3‑4, 2026.

Key Details

  • Injunction Outcome: Court denied the motion filed by David McGrath on grounds of insufficient likelihood of success and lack of irreparable harm.
  • Motion to Dismiss: Filed by Dr. Talal A. Debs, X Machina Capital Strategies Fund I GP LLC (XMC) and X Machina Capital Strategies LP (XMST); hearing set for March 19, 2026.
  • Debt Settlement Shares Issuance: 13,214,494 common shares issued on Jan 27, 2026 to interim CEO Catherine Flax, David McGrath, and Michael McGavick immediately before the record date for the annual general and special meeting scheduled for March 20, 2026.
  • BC Securities Commission Hearing: Concerned Shareholders seeking remedies (rescission of share issuance or prevention of voting) – hearing slated for March 3‑4, 2026.
  • Special Committee Investigation: Board formed a committee on Oct 9, 2025; external law firm reviewed ~US$30,000 of Dr. Debs’ expenses, finding only one claim (<US$600) in question; no material findings disclosed to shareholders.
  • Shareholder Ownership: Dr. Debs (as Managing Partner of XMC) controls 20,914,750 common shares (≈23.12% of outstanding), but will not vote 500,000 personally held shares per side‑letter agreement.
  • Proxy Solicitation Status: No proxy solicitation is being made at this time; Dr. Debs may file a dissident information circular prior to the March 20 meeting.
  • Forward‑Looking Statements: The release contains forward‑looking statements regarding future litigation actions and regulatory hearings, subject to risks and uncertainties.

Notable Quotes

(No direct quotes were provided in the release.)

Read the original news release →

More from ZEFIRO METHANE CORP.

Jun 30, 2026 · 05:01

Zefiro pivots to data-center infrastructure remediation, but liquidity remains tight and capital-dependent.

Production / Operations Jun 17, 2026 · 05:01

Zefiro Subsidiary Awarded USD $2.4 Million in Additional Federally Funded Projects to Plug 12 Orphan Wells in Ohio

Production / Operations Jun 12, 2026 · 05:01

Small capital raise to fund equipment expansion and international debut; execution risk remains high.

Financings Jun 10, 2026 · 05:01

New corporate accounts and $19.6M Ohio contract validate fleet expansion, but liquidity constraints and working capital deficit remain the primary near-term headwinds.

Production / Operations May 26, 2026 · 05:01

Zefiro ramps up rig count from Viking acquisition, but governance scars and heavy dilution keep the growth story firmly in “show‑me” territory.

Production / Operations May 14, 2026 · 17:02

Zefiro’s Q3 earnings confirm $11M quarterly revenue, debt slashed by a third, but the loss-making remediation firm still needs to prove its $40M run-rate can turn into profits.

Earnings